Error: Could not add to watchlist. X
+ Watchlist

KaloBios Pharmaceuticals Inc

0KB1:GR
Stuttgart
4.50
EUR
0.00
0.00%
As of 4:46 AM EST 1/19/2017
Open
3.67
Day Range
3.67 - 4.50
Volume
0
Previous Close
4.50
52Wk Range
1.24 - 13.00
1 Yr Return
61.23%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
3.67
Day Range
3.67 - 4.50
Volume
0
Previous Close
4.50
52Wk Range
1.24 - 13.00
1 Yr Return
61.23%
YTD Return
39.49%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (m EUR)
67.064
Shares Outstanding (m)
14.903
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.63%
% Price Change
-0.85%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
KaloBios Pharmaceuticals, Inc. operates as a biopharmaceutical company. The Company develops monoclonal antibodies designed to improve the lives of seriously ill patients with difficult-to-treat diseases, focusing on respiratory diseases and cancer such as cystic fibrosis, asthma, pneumonia, and tumors. KaloBios serves patients throughout the United States.
Address
442 Littlefield Avenue
South San Francisco, CA 94080
United States
Phone
1-650-243-3100
Show More